Webinar: Strengthening the future of the nuclear workforce
Join us for this online webinar to explore and discuss the huge opportunities in growing a dynamic and impactful future nuclear workforce.
Showing 801 - 820 of 971 results
Join us for this online webinar to explore and discuss the huge opportunities in growing a dynamic and impactful future nuclear workforce.
A large team of international researchers have used synchrotron techniques to understand how key proteins contribute to the virulence of the rabies virus, sometimes called the “zombie virus.”
Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
Part of the Large Hardon Collider
Shorebirds Competition 2022 results.
Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals
ANSTO is contributing to key critical minerals projects funded by the Federal Government.
A new systematic investigation of the origins of atomic structural distortions in compounds containing uranium has relevance for spent nuclear fuel .
As a Senior Principal Research Scientist, Henk is participating in several projects applying nuclear techniques to better understand climate changes of the past.
Role at ANSTO
Dr Richard Mole is an instrument scientist co-responsible for the cold-neutron time-of-flight spectrometer PELICAN.
Dr Storr has worked for over 40 years in nuclear science and technology in a range of positions spanning operations, research and executive management.
I am a particle physicist and a research leader at the ANSTO Human Health.
ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.
The use of radioisotopes, radiolabeled molecules and radioactive particles in conjunction with a range of quantitative imaging spectroscopy and radiation counting methods.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia